CEO of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Griffin Michelle Renee, sells 2,500 shares worth $96,400
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 16 07:00 PM, company CEO, Griffin Michelle Renee disclosed selling 2,500 shares at a cost of $38.56. At the time of this transaction (Jun 14), this trade was worth $96,400 in total. As of Jun 14, Griffin Michelle Renee now owns 1,504 shares in total worth about $56,926.4.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) CEO, Griffin Michelle Renee, we have the following information:
- SEC Form 4 filing: Apr 14: Sold 4,500 shares at the rate of $43.41 per share. Total worth of this trade was $195,345. Total number of shares owned as of Apr 14 were 1,504
- SEC Form 4 filing: Mar 15: Sold 4,500 shares at the rate of $41.75 per share. Total worth of this trade was $187,863. Total number of shares owned as of Mar 15 were 1,504
- SEC Form 4 filing: Mar 16: Sold 1,500 shares at the rate of $47.00 per share. Total worth of this trade was $70,500. Total number of shares owned as of Mar 16 were 1,504
Posted by
George Daniels
on Thursday June 17 2021, 10:34 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
